RAINBOW1,462.00

Rainbow Childrens Medicare Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISKIMSPOLYMEDPFIZERONESOURCEJUBLPHARMAVIJAYAMcap ₹14,848 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)52.9551.6266.9466.94
Receivable Days (DSO)19.8318.6122.1122.11
Payable Days (DPO)179.98170.34161.69150.39
Cash Conversion Cycle (days)-107.20-100.11-72.64-61.34
Working Capital Turnover2.752.223.563.80
Asset Turnover0.600.640.610.61
Cash Conversion (CFO/Net Income)1.471.621.491.49
CFO/EBITDA0.750.810.770.77
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.